Zimelidine‐induced variations in alcohol intake by nondepressed heavy drinkers

@article{Naranjo1984ZimelidineinducedVI,
  title={Zimelidine‐induced variations in alcohol intake by nondepressed heavy drinkers},
  author={C. Naranjo and E. Sellers and C. Roach and D. V. Woodley and M. Sanchez-Craig and K. Sykora},
  journal={Clinical Pharmacology \& Therapeutics},
  year={1984},
  volume={35}
}
The effect of zimelidine, a specific serotonin‐reuptake inhibitor, on alcohol intake was tested in 13 healthy male, nondepressed heavy drinkers who were randomly allocated to receive zimelidine or placebo in a double‐blind, crossover experiment. There were five 2‐wk experimental periods (baseline, placebo 1 and 2, and zimelidine 1 and 2). Treatment was discontinued in three subjects due to a suspected adverse reaction and three other subjects dropped out. Thus, 13 subjects participated in at… Expand
Differential effects of viqualine on alcohol intake and other consummatory behaviors
TLDR
It is indicated that viqualine both attenuates ethanol intake and reduces body weight in human beings. Expand
Citalopram decreases desirability, liking, and consumption of alcohol in alcohol‐dependent drinkers
TLDR
The findings indicate that serotonin uptake inhibitors may act by decreasing the urge to drink and the reinforcing effects of alcohol and a naturalistic outpatient trial is a sensitive, simple, and economic procedure for detecting these drug effects. Expand
Effect of citalopram on alcohol intake in heavy drinkers.
TLDR
Citalopram at the present dose appears capable of reducing alcohol intake only in a subgroup of heavy drinkers with a mean daily consumption of between 60 and 100 g pure alcohol. Expand
Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
TLDR
The findings with men who are problem drinkers indicate that fluoxetine differentially alters consummatory behaviors, and the reductions in alcohol intake and body weight are of clinical importance. Expand
The serotonin uptake inhibitor citalopram attenuates ethanol intake
TLDR
Citalopram, a selective serotonin uptake inhibitor, decreased the number of drinks consumed and increased the numbers of abstinent days in male nondepressed early‐stage problem drinkers and is probably through modulation of the neurobiologic mechanisms regulating ethanol intake. Expand
Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics
TLDR
It is indicated that enalapril does not alter alcohol intake in normotensive alcoholics with normal plasma renin activity and studies with higher doses of enAlapril in humans may be limited by increased frequency and severity of side effects. Expand
Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.
TLDR
Lower baseline drinking and higher level of education were significant and strong predictors of drinking reduction during treatment, and ondansetron was very well tolerated; hence, further long-term studies with 5-HT3 antagonists alone or in combination with other treatment components may offer promise for treatment of alcoholism. Expand
Efficacy of dexfenfluramine in the treatment of alcohol dependence.
TLDR
The results with dexfenfluramine are further evidence that serotonergic medications on their own do not significantly reduce alcohol consumption in alcohol-dependent individuals, and combination pharmacotherapy with agents that act on different receptors or neurotransmitter systems may be one way to enhanceSerotonergic effects on drinking behavior. Expand
Evaluation of the Effects of Serotonin Uptake Inhibitors in Alcoholics: A Review
TLDR
Patients with moderate dependence on alcohol showed a dose-dependent decrease in alcohol consumption, and SUI seem to have a differential effect on addictive behaviors since cigarette smoking did not decrease and consumption of nonalcoholic beverages was unaltered. Expand
Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake.
TLDR
An effect of combined psychosocial support with SSRI treatment with Zimelidine seems to be of clinical significance, and no effect was observed on the amount of daily alcohol intake on drinking days. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Alcohol and central serotonin metabolism in man.
TLDR
The CSF metabolites of serotonin and dopamine, 5-hydroxyindoleacetic acid, and homovanillic acid were studied in hospitalized alcoholics, and there were no significant differences in HVA levels between groups. Expand
Zimelidine: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness
TLDR
Clinical experience with zimelidine to date has been limited, and further well designed studies are required to define the role of the drug more clearly in treating depressive illness compared with other antidepressants, and particularly to define whether some types of depression may respond more readily to zIMelidine than to other antidepressants. Expand
Pharmacological control of alcohol consumption: tactics for the identification and testing of new drugs.
TLDR
A better knowledge of the neurochemical basis of alcohol consumption should lead to the identification of more specific and active pharmacologic treatments, and the efficacy and safety of these drugs must be assessed according to the classic four phases of human pharmacology. Expand
Reduction of voluntary morphine consumption following treatment with zimelidine.
TLDR
Treatment with zimelidine was shown to significantly attenuate morphine drinking suggesting that an increased availability of serotonin may interfere with the positive reinforcing properties of morphine. Expand
5-Hydroxytryptophan-induced conditioned taste aversion to ethanol in the rat
TLDR
The results have indicated that simple CS-UCS associative learning mechanisms are probably not a primary causative factor in the persistent ethanol rejection until death observed in rats treated with 5-HTP. Expand
Attenuation of ethanol intake by 5-hydroxytryptamine uptake blockade in laboratory rats. I. Involvement of brain 5-hydroxytryptamine in the mediation of the positive reinforcing properties of ethanol.
TLDR
The role of 5-hydroxytryptamine (5-HT) uptake blockade in the mediation of the positive reinforcing peroperties of ethanol in male wistar rats was investigated and treatment with zimelidine a 5-HT uptake inhibitor, specifically attenuated ethanol consumption. Expand
Reversed-phase chromatography of zimelidine and similar dibasic amines. I. Analysis in biological material.
TLDR
It is demonstrated that the quality of the quantitations are improved by use of an internal standard, norzimelidine E-isomer, and the precisions obtained for both compounds at the concentration levels of 300 and 1500 nmol/1 are 5--6% and 2% respectively for within-run variations, and 8--9% and 5% respectivelyfor day-to-day-variations. Expand
A comparison of the inhibitory effects of new non-tricyclic amine uptake inhibitors on the uptake of norepinephrine and 5-hydroxytryptamine into synaptosomes of the rat brain
TLDR
The ability of FS32 to inhibit [ 3 H]-5-HT uptake was almost equal to that of nortriptyline, while FS97 was two times more potent than iprindole in inhibiting this uptake. Expand
A new depression scale designed to be sensitive to change.
TLDR
The construction of a depression rating scale designed to be particularly sensitive to treatment effects is described, and its capacity to differentiate between responders and non-responders to antidepressant treatment was better than the HRS, indicating greater sensitivity to change. Expand
The Michigan alcoholism screening test: the quest for a new diagnostic instrument.
  • M. Selzer
  • Medicine
  • The American journal of psychiatry
  • 1971
The Michigan Alcoholism Screening Test (MAST), devised to provide a consistent, quantifiable, structured interview instrument to detect alcoholism, consists of 25 questions that can be rapidlyExpand
...
1
2
3
...